Parallax Volatility Advisers, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 102 filers reported holding HERON THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$286,000
-53.2%
50,000
+100.0%
0.00%
-100.0%
Q1 2019$611,000
-91.9%
25,000
-87.0%
0.00%
-90.9%
Q2 2018$7,498,000
+5898.4%
193,000
+2702.0%
0.01%
Q4 2017$125,000
+197.6%
6,888
+166.9%
0.00%
Q3 2017$42,000
+425.0%
2,581
+330.9%
0.00%
Q2 2017$8,000
-11.1%
5990.0%0.00%
Q1 2017$9,000
+12.5%
5990.0%0.00%
Q4 2016$8,000
-20.0%
5990.0%0.00%
Q3 2016$10,000
-97.2%
599
-97.0%
0.00%
-100.0%
Q2 2016$361,000
+3181.8%
20,000
+3238.9%
0.00%
Q1 2016$11,000
-84.7%
599
-77.8%
0.00%
Q4 2015$72,000
-97.7%
2,699
-97.9%
0.00%
-100.0%
Q3 2015$3,167,000129,8000.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders